Coldstream Capital Management Inc Apellis Pharmaceuticals, Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
295Shares Held
121MCall Options Held
1.9MPut Options Held
818K-
Wellington Management Group LLP Boston, MA12.3MShares$246 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$244 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$238 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$202 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$192 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...